Viking Therapeutics (VKTX) Assets Average (2015 - 2026)
Viking Therapeutics' (VKTX) quarterly Assets Average came in at $565.1 million in Q2 2026, down 33.32% year-over-year from $847.4 million in Q2 2025, and down 14.64% quarter-over-quarter from $662.0 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Assets Average (2015 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Assets Average across 12 years of filings, most recently posting $565.1 million for Q2 2026.
- In Q2 2026, Assets Average fell 33.32% year-over-year to $565.1 million; the TTM figure through Jun 2026 stood at $565.1 million (down 33.32% YoY), while the FY2025 annual figure was $812.0 million, up 27.2% from the prior year.
- Assets Average came in at $565.1 million for Q2 2026 at Viking Therapeutics, down from $662.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $957.2 million in Q2 2024 to a low of $159.7 million in Q1 2023.
- Average Assets Average over 5 years is $550.0 million, with a median of $613.5 million recorded in 2026.
- Year-over-year, Assets Average soared 318.26% in 2024 and tumbled 33.32% in 2026.
- Over 5 years, Assets Average stood at $167.6 million in 2022, then jumped by 124.08% to $375.6 million in 2023, then surged by 145.78% to $923.1 million in 2024, then slipped by 21.18% to $727.6 million in 2025, then slipped by 22.33% to $565.1 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $565.1 million in Q2 2026, $662.0 million in Q1 2026, and $727.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 114.92 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 94.07 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 52.82 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 204.57 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 26.95 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 565.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 565.07 Mn |
| Mar 31, 2026 | 661.99 Mn |
| Dec 31, 2025 | 727.57 Mn |
| Sep 30, 2025 | 783.63 Mn |
| Jun 30, 2025 | 847.42 Mn |
| Mar 31, 2025 | 887.66 Mn |
| Dec 31, 2024 | 923.10 Mn |
| Sep 30, 2024 | 942.36 Mn |
| Jun 30, 2024 | 957.18 Mn |
| Mar 31, 2024 | 668.00 Mn |
| Dec 31, 2023 | 375.58 Mn |
| Sep 30, 2023 | 391.68 Mn |
| Jun 30, 2023 | 275.79 Mn |
| Mar 31, 2023 | 159.71 Mn |
| Dec 31, 2022 | 167.61 Mn |
| Sep 30, 2022 | 174.10 Mn |
| Jun 30, 2022 | 188.27 Mn |
| Mar 31, 2022 | 202.85 Mn |
| Dec 31, 2021 | 217.57 Mn |
| Sep 30, 2021 | 231.16 Mn |
API Access
Viking Therapeutics Assets Average API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets-average&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets-average", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets-average&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();